EOLS - Multiplikator forward rega marang pendapatan Jeuveau
Amid the implementation of AI platforms to automate customer service in aesthetic medicine, the expected P/S dynamics of Evolus, Inc. (EOLS) objectively capture the asset's market value. The value 1.50 serves as the baseline valuation metric. However, the risk of declining consumer spending and price wars are squeezing margins, while the brand's success relies on millennial loyalty and the reliability of overseas supplies.
Rincian analitis perusahaan Evolus, Inc.
- rega pasar lan target rega analis:
- statistik kapitalisasi pasar:
- rincian valuasi buku bisnis:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Evolus, Inc.|EOLS - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Evolus, Inc.|EOLS - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Evolus Corp|EOLS - Kewajiban jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Evolus|Rasio cepet evolus.com
- data bathi bisnis lan rasio investasi:
EOLS - Penghasilan resik perusahaan|Bathi sing dikarepake Evolus, Inc.|EOLS - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Jeuveau|EOLS - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Evolus Corp|EOLS - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Evolus|EOLS - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan evolus.com|EOLS - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Evolus, Inc.
- indikator volume dodolan lan pendapatan:
Pambiji fundamental perusahaan:Evolus EOLS
Evolus, Inc. is scaling its medical record automation software and testing physical robots as it moves toward the systemic implementation phase of these technologies. The ratio of market capitalization to projected revenue measures the premium for future growth; therefore, the forward P/S multiple on GURU.Markets allows an investor to determine the extent of the overpayment for the company's status as a defensive asset or to identify an undervaluation of the business.
Pesaing Evolus, Inc. (EOLS)
Rasio rega marang prakiraan pendapatan HCA Healthcare HCA|Tenet Healthcare Corp - Rasio rega marang prakiraan pendapatan|FMS: Multiplikator forward rega marang pendapatan|SOLV - Multiplikator Forward P/S|Encompass Health (EHC) - Rasio rega marang prakiraan pendapatan|UHS - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan DVA|RDNT: Rega forward marang dodolan|Multiplikator Forward P/S OPCH|Rasio kapitalisasi marang dodolan sing dikarepake Surgery Partners Group|Rasio rega marang prakiraan pendapatan Premier, Inc. PINC|EYE: Kapitalisasi marang prakiraan pendapatan|Progyny - Multiplikator Forward P/S|Ardent Health (ARDT) - Multiplikator forward rega marang pendapatan|SEM (Select Medical Corp) - Multiplikator forward rega marang pendapatan|ASTH - Rasio kapitalisasi marang dodolan sing dikarepake|MD (Pediatrix Corp) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep US Physical Therapy Inc USPH|Rasio rega marang prakiraan pendapatan The Pennant Group (PNTG)|ORGO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Nutex Health Corp NUTX|Auna Corp - Rasio rega marang prakiraan pendapatan|SBC - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake chs.net CYH|SKIN (beautyhealth.com) - Multiplikator forward rega marang pendapatan|MDWD: Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan Biote Corp|JYNT: Rega forward marang dodolan|Multiplikator Forward P/S DCGO|PIII - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S GANX (Gain Therapeutics)|Multiplikator Forward P/S EUDA Health Holdings EUDA|BMGL: Multiplikator forward rega marang pendapatan|CollPlant Biotechnologies - Rasio rega marang pendapatan sing dikarepake|Cuprina Holdings (Cayman) Ltd (CUPR) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan concordmedical.com|AMS (American Shared Hospital Services) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep MEDIROM Healthcare Group Inc. MRM|Rasio rega marang prakiraan pendapatan Avalon GloboCare (ALBT)|DIH Group - Kapitalisasi marang prakiraan pendapatan|Longevity Health Holdings - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake NIVF (newgenivf.com)|ATI Physical Therapy Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep CareMax Inc.|KDLY (Kindly MD Corp) - Multiplikator forward rega marang pendapatan|MODV (ModivCare Corp) - Rasio rega marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Novo Integrated Sciences|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep SunLink Health Systems, Inc SSY|Rasio rega marang prakiraan pendapatan IMAC Holdings (BACK)
